Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
- 1 March 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 339 (8793) , 576-580
- https://doi.org/10.1016/0140-6736(92)90866-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- p53 immunostaining as a marker of malignant disease in diagnostic cytopathologyThe Lancet, 1991
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrationsThe Lancet, 1991
- Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinomaBiochemical and Biophysical Research Communications, 1990
- Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.Journal of Clinical Investigation, 1990
- Review of Radon and Lung Cancer RiskRisk Analysis, 1990
- Comparison of radon-daughter-induced effects in repair-proficient and repair-deficient cho cell linesEnvironmental and Molecular Mutagenesis, 1990
- Radon Progeny Exposure and Lung Cancer Risk in New Mexico U MinersHealth Physics, 1989
- Gene Amplification of c- myc and N- myc in Small Cell Carcinoma of the LungScience, 1986